Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

Published:2014-06 Issue:9935 Volume:383 Page:2136-2143
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bhandari Nita,Rongsen-Chandola Temsunaro,Bavdekar Ashish,John Jacob,Antony Kalpana,Taneja Sunita,Goyal Nidhi,Kawade Anand,Kang Gagandeep,Rathore Sudeep Singh,Juvekar Sanjay,Muliyil Jayaprakash,Arya Alok,Shaikh Hanif,Abraham Vinod,Vrati Sudhanshu,Proschan Michael,Kohberger Robert,Thiry Georges,Glass Roger,Greenberg Harry B,Curlin George,Mohan Krishna,Harshavardhan G V J A,Prasad Sai,Rao T S,Boslego John,Bhan Maharaj Kishan

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study;Kotloff;Lancet,2013

2. Rotavirus vaccines. WHO position paper–January 2013;Wkly Epidemiol Rec,2013

3. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine;Vesikari;N Engl J Med,2006

4. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis;Ruiz-Palacios;N Engl J Med,2006

5. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study;Vesikari;Lancet,2007

Cited by 246 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Success from the South: the rotavirus vaccine story and its lessons;The Lancet;2024-01

2. Renal Disease in the Tropics;Manson's Tropical Diseases;2024

3. Rotavirus;Molecular Medical Microbiology;2024

4. Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach;PLOS ONE;2023-11-17

5. Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants;Human Vaccines & Immunotherapeutics;2023-11-15